GURU.Markets stock price, segment price, and overall market index valuation
The company's share price vTv Therapeutics Inc.
vTv Therapeutics is a biotech company developing drugs to treat metabolic diseases. Its stock price is highly volatile, reflecting its complex clinical trials and ongoing partnerships for further development.
Share prices of companies in the market segment - Pharma metabolism
vTv Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule drugs for the treatment of type 1 diabetes, psoriasis, and other conditions. We have classified it in the "Pharma Metabolism" segment. The chart below shows the overall dynamics in the pharmaceutical sector, where the search for new oral treatments for chronic diseases is underway.
Broad Market Index - GURU.Markets
vTv Therapeutics is a biopharmaceutical company developing small-molecule drugs for the treatment of diabetes and other metabolic diseases. Its scientific advancements make it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how vTv compares to it.
Change in the price of a company, segment, and market as a whole per day
VTVT - Daily change in the company's share price vTv Therapeutics Inc.
For vTv Therapeutics, a diabetes drug developer, daily price change is a measure of its enormous volatility. This metric reflects extreme sensitivity to clinical trial data and is key to biotech risk assessment formulas.
Daily change in the price of a set of shares in a market segment - Pharma metabolism
vTv Therapeutics Inc. is a biotech company. This chart highlights the extreme volatility of the sector. Comparison with VTVT's dynamics, which depend on clinical trial results, helps assess it as a high-risk asset compared to more diversified companies.
Daily change in the price of a broad market stock, index - GURU.Markets
vTv Therapeutics is a biotech company developing oral medications for diabetes and other metabolic diseases. Its shares react sharply to news of clinical trials. This battle to create convenient medications for millions of people creates its own unique medical rhythm, influencing the overall market pulse on the chart.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization vTv Therapeutics Inc.
vTv Therapeutics Inc.'s year-over-year performance is a story of developing a new generation of drugs for the treatment of diabetes and Alzheimer's disease. Its 12-month market cap is entirely dependent on clinical trial data. The success of its RAGE inhibitors could lead to a breakthrough in the treatment of diabetes complications and offer a new approach to neurodegenerative diseases.
Annual dynamics of market capitalization of the market segment - Pharma metabolism
vTv Therapeutics Inc. is a clinical-stage biotech developing oral medications for diabetes and other metabolic diseases. Its stock price is entirely dependent on clinical trial results. The chart reflects the high risks and potential for breakthroughs in this vast but competitive field.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
vTv Therapeutics is a clinical-stage biotech whose fate depends on scientific breakthroughs, not the state of the economy. Its stock price reflects investor hopes for the success of new drug trials. The company's chart exists in a world of its own, where the main events are data releases.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization vTv Therapeutics Inc.
vTv Therapeutics is a clinical-stage biotech focused on diabetes and metabolic diseases. Its monthly performance is entirely dependent on the results of its clinical trials. Data on its key drugs is a binary outcome event for its stock.
Monthly dynamics of market capitalization of the market segment - Pharma metabolism
vTv Therapeutics is a clinical-stage biotech company focused on treating diabetes and Alzheimer's disease. Its future depends on the results of clinical trials in these highly complex areas. The biotech sector's timeline reflects the high risks and potential rewards associated with drug discovery for these common diseases.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
vTv Therapeutics is a biotech company developing drugs to treat diabetes and other metabolic diseases. Its shares are driven by anticipation of clinical trial results. Monthly performance has little correlation with the market, as investors evaluate scientific prospects rather than macroeconomic data.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization vTv Therapeutics Inc.
For vTv Therapeutics, a clinical-stage biopharmaceutical company, weekly price movements are extremely volatile. News of trial results for its diabetes and Alzheimer's drugs, as well as FDA decisions, are the main factors driving sharp price surges.
Weekly dynamics of market capitalization of the market segment - Pharma metabolism
vTv Therapeutics shares, like the entire clinical-stage biotech sector, are highly dependent on overall investor risk sentiment. Regulatory news and scientific breakthroughs can boost the entire industry. The chart will show how the company stacks up against this high-risk segment.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
vTv Therapeutics shares, like the entire clinical-stage biotech sector, are highly dependent on overall investor risk sentiment. Regulatory news and scientific breakthroughs can boost the entire industry. The chart will show how the company stacks up against this high-risk segment.
Market capitalization of the company, segment and market as a whole
VTVT - Market capitalization of the company vTv Therapeutics Inc.
The vTv Therapeutics market capitalization chart is a financial history of the long and arduous search for a cure for diabetes and Alzheimer's. It reflects both past clinical trial failures and current hopes for the molecules remaining in development. Its low market capitalization reflects the market's assessment of the low chances of success after years of research.
VTVT - Share of the company's market capitalization vTv Therapeutics Inc. within the market segment - Pharma metabolism
vTv Therapeutics is a clinical-stage biopharmaceutical company focused on developing oral medications for diabetes and other metabolic diseases. Its sector share reflects the potential of its research and development pipeline. The chart below shows how its share changes based on clinical trial results.
Market capitalization of the market segment - Pharma metabolism
vTv Therapeutics specializes in developing drugs to treat metabolic diseases such as diabetes. The chart below shows the total market capitalization of this entire sector. Its growth reflects the scale of the global diabetes epidemic and the need for new, more effective treatments.
Market capitalization of all companies included in a broad market index - GURU.Markets
The biotech companies visible on the chart are seeking solutions for widespread diseases like diabetes and Alzheimer's. vTv Therapeutics is developing small molecules to treat these conditions. Its small market cap reflects the long and risky path of clinical research that could lead to a breakthrough.
Book value capitalization of the company, segment and market as a whole
VTVT - Book value capitalization of the company vTv Therapeutics Inc.
For vTv Therapeutics, this graph represents capital for the fight against diabetes and Alzheimer's disease. The company's book value at the clinical development stage consists of financial reserves. These assets are being used for expensive research into its oral drugs for the treatment of metabolic diseases.
VTVT - Share of the company's book capitalization vTv Therapeutics Inc. within the market segment - Pharma metabolism
vTv Therapeutics, a biopharmaceutical company, focuses on developing drugs for metabolic diseases. Its share of the sector's assets is represented by its R&D centers and laboratories. The chart shows that the company is investing in building a scientific base that forms the foundation for its clinical programs.
Market segment balance sheet capitalization - Pharma metabolism
vTv Therapeutics is a biotech company focused on R&D, making its model intellectually rather than capital-intensive. The company's value lies in its scientific platform and clinical trial data. Compared to the biotech sector as a whole, its "light" balance sheet is typical of companies that prioritize technology over production.
Book value of all companies included in the broad market index - GURU.Markets
vTv Therapeutics' assets represent scientific capital focused on drug discovery for diabetes and Alzheimer's disease. The company's balance sheet reflects the value of its unique small molecules and clinical trial data. The chart shows the resources invested in tackling the leading diseases of aging.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - vTv Therapeutics Inc.
vTv Therapeutics is a clinical-stage biopharmaceutical company. Its market capitalization is a barometer of investor hopes for the success of its research into diabetes and Alzheimer's disease. Its book value is minimal, and its market valuation represents an option price for a future scientific breakthrough.
Market to book capitalization ratio in a market segment - Pharma metabolism
vTv Therapeutics is a biotech company focused on treating metabolic diseases such as diabetes. Its market cap reflects investors' bets on the success of its clinical programs. This chart clearly demonstrates how expectations of future breakthroughs shape a valuation that bears little relation to current tangible assets.
Market to book capitalization ratio for the market as a whole
vTv Therapeutics is a biopharmaceutical company focused on treating metabolic diseases such as diabetes. Its market capitalization is based on the potential of its scientific developments. This chart demonstrates how much a biotech company's valuation can exceed its book value thanks to the strength of its intellectual property.
Debts of the company, segment and market as a whole
VTVT - Company debts vTv Therapeutics Inc.
vTv Therapeutics is a biopharmaceutical company focused on treating metabolic diseases. Conducting clinical trials requires significant and long-term financial commitments. This chart illustrates how the company may use debt to finance its research programs on the path to commercialization.
Market segment debts - Pharma metabolism
vTv Therapeutics is a biopharmaceutical company focused on metabolic diseases such as diabetes. Funding clinical trials is its primary objective. This chart shows the company's chosen financing path: traditional shareholder dilution through a share issue or debt financing from partners or specialized funds.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio vTv Therapeutics Inc.
vTv Therapeutics, which focuses on treating metabolic diseases such as diabetes, incurs massive research expenses. This chart shows the proportion of its capital leveraged. This is common practice for a biotech company, but the risks are high: a failed clinical trial could wipe out years of work, leaving behind only accumulated debt.
Market segment debt to market segment book capitalization - Pharma metabolism
vTv Therapeutics is a biopharmaceutical company focused on treating metabolic diseases, primarily diabetes. This chart compares its debt, raised to fund lengthy and expensive clinical trials, to the overall market capitalization of the entire sector. It illustrates the financial implications of fighting one of the world's most prevalent diseases.
Debt to book value of all companies in the market
vTv Therapeutics develops drugs for the treatment of metabolic diseases, which require lengthy clinical trials. This chart provides insight into how the company manages its debt amid the need for ongoing R&D funding. Deviations from market benchmarks may signal a unique strategy or an impending breakthrough.
P/E of the company, segment and market as a whole
P/E - vTv Therapeutics Inc.
For vTv Therapeutics, a biopharmaceutical company focused on treating metabolic diseases, this chart reflects the long and risky path of drug development. The stock price relative to potential earnings reflects investors' confidence in the success of its clinical programs. The price action reflects scientific data, not current revenue.
P/E of the market segment - Pharma metabolism
This chart reflects the average valuation for the speculative biotech sector—a benchmark for vTv Therapeutics. For investors, it represents a benchmark for the overall level of optimism surrounding metabolic disease treatments. This provides a useful backdrop for assessing expectations for vTv's developments, especially after previous research setbacks.
P/E of the market as a whole
vTv Therapeutics is a clinical-stage biotech company focused on treating metabolic diseases such as diabetes. Its valuation is directly dependent on clinical trial results. This chart reflects investors' overall risk appetite. It allows one to assess whether vTv Therapeutics is riding the wave of general interest in biotech or whether its valuation is governed by its own laws, dictated by scientific data.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company vTv Therapeutics Inc.
vTv Therapeutics is a clinical-stage biopharmaceutical company focused on treating diabetes and other metabolic diseases. This chart reflects analyst expectations for the results of its clinical programs. It essentially represents a bet that one of its drug candidates will successfully complete trials and reach the market.
%20P%2FE%20vTv%20Therapeutics%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-vTv-Therapeutics-Inc.&v=1772650123979 "Chart of the company's future (projected) P/E vTv Therapeutics Inc.")
Future (projected) P/E of the market segment - Pharma metabolism
vTv Therapeutics is a biopharmaceutical company focused on developing oral medications for diabetes and other metabolic diseases. The chart shows how the company's revenue forecasts compare to the industry average. This reflects how the market perceives the scientific potential of its platform and the risks associated with clinical trials.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20metabolism&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-metabolism&v=1772650123991 "Future (projected) P/E graph of the market segment - Pharma metabolism")
Future (projected) P/E of the market as a whole
vTv Therapeutics is a clinical-stage biopharmaceutical company focused on treating metabolic diseases such as diabetes. This chart shows the overall risk appetite of investors. vTv's success depends solely on scientific data. Positive market expectations help attract capital, but they cannot replace successful trial results.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772650124010 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit vTv Therapeutics Inc.
vTv Therapeutics is a clinical-stage biopharmaceutical company focused on treating metabolic diseases such as diabetes. This chart shows the financial trajectory of its research. Current figures reflect the costs of conducting clinical trials in the hopes of developing and bringing new, effective drugs to market.
Profit of companies in the market segment - Pharma metabolism
vTv Therapeutics is a biopharmaceutical company focused on developing oral medications for diabetes and other metabolic diseases. This is a huge and highly competitive market. This chart illustrates the total profitability of the pharmaceutical sector, demonstrating the commercial success of new approaches to treating widespread diseases.
Overall market profit
vTv Therapeutics is a clinical-stage biotech company focused on treating diabetes and other metabolic diseases. Its value is determined by the potential of its lead candidates. It's an example of a business that can rise or fall after the release of key data, regardless of the economic climate.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company vTv Therapeutics Inc.
vTv Therapeutics is a biotechnology company focused on developing drugs to treat metabolic diseases such as diabetes. The company's prospects are inextricably linked to clinical trial results. These reflect market expectations for future revenue, which are entirely dependent on the success of its research.
%20profit%20of%20the%20company%20vTv%20Therapeutics%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-vTv-Therapeutics-Inc.&v=1772650124053 "Graph of future (projected) profit of the company vTv Therapeutics Inc.")
Future (predicted) profit of companies in the market segment - Pharma metabolism
vTv Therapeutics is a biopharmaceutical company focused on developing drugs for diabetes and Alzheimer's disease. This chart shows forecasts for the pharmaceutical sector, which has vast markets. vTv's future profitability depends on its ability to demonstrate the efficacy of its drugs in treating these widespread diseases.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20metabolism&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-metabolism&v=1772650124071 "Graph of future (predicted) profits of companies in a market segment - Pharma metabolism")
Future (predicted) profit of the market as a whole
vTv Therapeutics is a biotech company focused on treating metabolic diseases such as diabetes. Its success depends on clinical trial results and its ability to raise capital. The overall profit forecast, shown in the chart, impacts the investment climate and funding availability for companies in the R&D stage.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772650124093 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - vTv Therapeutics Inc.
vTv Therapeutics is a biopharmaceutical company focused on treating diabetes and other metabolic diseases. Because the company is in clinical development, this chart represents an estimate of its future potential, not current sales. It reflects investors' confidence in the success of its research.
P/S market segment - Pharma metabolism
vTv Therapeutics is a clinical-stage biopharmaceutical company focused on developing oral medications for diabetes and other metabolic disorders. Its valuation is dependent on clinical trial results. This chart reflects the average biotech valuation, helping to understand how highly the market values vTv's development potential compared to its peers.
P/S of the market as a whole
vTv Therapeutics is a biopharmaceutical company focused on developing drugs to treat metabolic diseases such as diabetes. The company is in clinical trials. This revenue valuation indicator emphasizes that investors are evaluating scientific potential and potential future breakthroughs, not current sales.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company vTv Therapeutics Inc.
vTv Therapeutics is a clinical-stage biopharmaceutical company focused on treating metabolic diseases such as diabetes. This chart shows how investors assess the future commercial potential of its developments. This assessment is based on expectations of positive clinical trial results, which could lead to significant revenue.
%20P%2FS%20vTv%20Therapeutics%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-vTv-Therapeutics-Inc.&v=1772650124123 "The graph of the company's future (projected) P/S vTv Therapeutics Inc.")
Future (projected) P/S of the market segment - Pharma metabolism
vTv Therapeutics is a clinical-stage biopharmaceutical company focused on treating metabolic diseases such as diabetes. This chart compares the company's future revenue expectations with its industry sector. It provides an indication of investor confidence in the scientific potential of its developments and the future commercial success of its drugs.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20metabolism&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-metabolism&v=1772650124125 "Future (projected) P/S market segment graph - Pharma metabolism")
Future (projected) P/S of the market as a whole
vTv Therapeutics is a biopharmaceutical company focused on developing small-molecule drugs for the treatment of diabetes and other metabolic diseases. The optimism expressed by this indicator is often fueled by breakthroughs in the treatment of chronic diseases. Success at vTv Therapeutics could radically change therapeutic approaches and create a huge market.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772650124131 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales vTv Therapeutics Inc.
vTv Therapeutics is a clinical-stage biopharmaceutical company specializing in the treatment of metabolic diseases such as diabetes. Its revenue, shown in this chart, is generated not from sales but from upfront fees and research funding from major pharmaceutical partners under licensing agreements.
Sales of companies in the market segment - Pharma metabolism
vTv Therapeutics is a biopharmaceutical company focused on treating metabolic diseases such as diabetes. Their research is aimed at creating new classes of drugs to address unmet medical needs. This chart shows the total revenue of the pharmaceutical sector, where breakthroughs in treating common diseases can create multibillion-dollar markets.
Overall market sales
vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on treating metabolic diseases such as diabetes. Its operations require significant investment. The growth in overall economic activity, reflected in this chart, creates a more favorable environment for raising capital. Investors are more willing to fund long-term research during periods of economic growth.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company vTv Therapeutics Inc.
vTv Therapeutics is a biotech company focused on developing oral medications for the treatment of diabetes and other metabolic diseases. The forecast on this chart reflects analyst expectations for the clinical trial results of its key candidates, which may offer a more convenient alternative to injectable medications.
%20sales%20of%20the%20company%20vTv%20Therapeutics%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-vTv-Therapeutics-Inc.&v=1772650124186 "Schedule of future (projected) sales of the company vTv Therapeutics Inc.")
Future (projected) sales of companies in the market segment - Pharma metabolism
vTv Therapeutics is a biopharmaceutical company focused on developing oral medications for the treatment of type 2 diabetes and other metabolic diseases. This chart shows general forecasts for the pharmaceutical sector, allowing one to assess the significance of the market vTv is targeting and the potential impact of a successful drug launch.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20metabolism&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-metabolism&v=1772650124194 "Schedule of future (projected) sales of companies in the market segment - Pharma metabolism")
Future (projected) sales of the market as a whole
vTv Therapeutics, which focuses on treating metabolic diseases such as diabetes, sees this chart as a marker affecting healthcare budgets. The stable economics reflected here ensures predictability in chronic disease treatment costs, which is important for patient access to the company's new drugs.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772650124204 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality vTv Therapeutics Inc.
vTv Therapeutics is a clinical-stage biopharmaceutical company focused on treating diabetes and Alzheimer's disease. The company is actively investing in research. This chart is less about profits than about cost management efficiency. It shows how investor capital is being used to advance clinical trials.
Market segment marginality - Pharma metabolism
vTv Therapeutics is a biopharmaceutical company focused on treating metabolic diseases such as diabetes. This chart helps understand how effectively the company manages its resources during expensive research and development. Strong performance may indicate a promising drug pipeline or a well-balanced R&D strategy.
Market marginality as a whole
vTv Therapeutics is a clinical-stage biopharmaceutical company focused on diabetes treatment. This chart shows average market margins, but vTv is solving one of the biggest healthcare problems. Their financial track record points them toward a potential blockbuster with the potential to generate massive profits.
Employees in the company, segment and market as a whole
Number of employees in the company vTv Therapeutics Inc.
vTv Therapeutics is a biotech company focused on treating metabolic diseases. The size of its team, comprised of scientists and clinical trial specialists, is directly reflected in this chart. It demonstrates the human resources required to conduct complex and lengthy clinical trials.
Share of the company's employees vTv Therapeutics Inc. within the market segment - Pharma metabolism
vTv Therapeutics focuses on treating metabolic diseases such as diabetes. Its success depends entirely on its team of research scientists. This chart shows the percentage of its scientific talent concentrated in its narrow therapeutic area. This is a direct indicator of its research capacity and ambition in the fight against chronic diseases.
Number of employees in the market segment - Pharma metabolism
vTv Therapeutics is a biopharmaceutical company focused on treating metabolic diseases such as diabetes. Its core resource is its scientific team. This chart shows the company's investment in R&D. Headcount trends reflect clinical trial activity and progress in developing new therapeutic candidates.
Number of employees in the market as a whole
vTv Therapeutics is a biopharmaceutical company focused on treating metabolic diseases. Its success and workforce growth depend on laboratory breakthroughs, not overall economic employment. This chart shows the macro level, while vTv prioritizes clinical trial results and patents.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company vTv Therapeutics Inc. (VTVT)
vTv Therapeutics is an R&D company where a few dozen scientists can create a drug worth billions. This chart clearly demonstrates how the market values intellectual capital. A high value indicates that the company's value lies in its scientific developments, not its headcount.
%20of%20the%20company%20vTv%20Therapeutics%20Inc.%20(VTVT)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-vTv-Therapeutics-Inc.-VTVT&v=1772650124274 "Chart of market capitalization per employee (in thousands of dollars) of the company vTv Therapeutics Inc. (VTVT)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma metabolism
vTv Therapeutics develops oral medications for the treatment of metabolic diseases such as diabetes. In biotech, market valuations often outpace current revenue based on the potential of future drugs. This chart compares how highly investors value the vTv team's scientific potential per person relative to its competitors.
%20by%20market%20segment%20-%20Pharma%20metabolism&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-metabolism&v=1772650124275 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma metabolism")
Market capitalization per employee (in thousands of dollars) for the overall market
vTv Therapeutics is a biotech company focused on treating metabolic diseases such as diabetes. The company's clinical-stage value depends on trial results. This chart illustrates how investors have high expectations for a small team of scientists whose work could lead to the development of sought-after drugs.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772650124276 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company vTv Therapeutics Inc. (VTVT)
vTv Therapeutics is a biopharmaceutical company focused on treating metabolic diseases such as diabetes. It's a knowledge-intensive business. This chart reflects the efficiency of their R&D. During the research phase, it shows the capital burn per scientist, but if a single drug is successful, this figure can skyrocket, demonstrating the enormous value of their intellectual capital.
%20Chart%20vTv%20Therapeutics%20Inc.%20(VTVT)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-vTv-Therapeutics-Inc.-VTVT&v=1772650124279 "Company Profit Per Employee (in thousands of dollars) Chart vTv Therapeutics Inc. (VTVT)")
Profit per employee (in thousands of dollars) in the market segment - Pharma metabolism
vTv Therapeutics (VTVT) is a biopharmaceutical company focused on developing drugs for metabolic diseases such as diabetes. This chart is crucial for evaluating R&D companies. It doesn't reflect sales revenue, but rather how effectively the team of scientists and management manages capital to advance complex molecules through expensive clinical trials.
%20in%20the%20market%20segment%20-%20Pharma%20metabolism&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-metabolism&v=1772650124301 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma metabolism")
Profit per employee (in thousands of dollars) for the market as a whole
vTv Therapeutics is a biotech company focused on metabolic diseases such as diabetes. The chart below reflects the harsh reality of R&D: the company invests in scientists and doctors, generating losses per employee until the drug is commercialized. A positive trend would indicate a major deal or drug approval.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772650124311 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee vTv Therapeutics Inc. (VTVT)
vTv Therapeutics is a biopharmaceutical company focused on treating metabolic diseases such as diabetes. This chart illustrates the long road to drug development. Revenue per employee, if any, likely comes from partnerships and is an indicator of progress in clinical trials, rather than direct sales.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-vTv-Therapeutics-Inc.-VTVT&v=1772650124331 "Sales chart per company employee vTv Therapeutics Inc. (VTVT)")
Sales per employee in the market segment - Pharma metabolism
vTv Therapeutics is a biotech company focused on developing small-molecule drugs for the treatment of metabolic diseases such as diabetes. This chart shows the average revenue per employee in the sector. For a company in clinical development, this is an important benchmark. It demonstrates the level of productivity the sector aspires to achieve and helps assess future commercial viability.
Sales per employee for the market as a whole
vTv Therapeutics Inc. is a clinical-stage biotech company specializing in the treatment of metabolic diseases such as diabetes. The company's entire staff, consisting of scientists and managers, is focused on R&D. This graph shows the current commercial return per employee, which is close to zero, which is typical for R&D companies before drug approval.
Short shares by company, segment and market as a whole
Shares shorted by company vTv Therapeutics Inc. (VTVT)
vTv Therapeutics is a clinical-stage biotech focused on metabolic diseases such as type 1 diabetes. The company has experienced several significant trial failures. This chart shows the number of investors betting that its current candidate programs will also fail, devaluing the company's years of development.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-vTv-Therapeutics-Inc.-VTVT&v=1772650124367 "Short Shares Chart for the Company vTv Therapeutics Inc. (VTVT)")
Shares shorted by market segment - Pharma metabolism
vTv Therapeutics is focused on treating metabolic diseases such as diabetes. This indicator reflects the overall sentiment in the sector. Its rise signals investor skepticism about the entire therapeutic area, possibly due to intense competition or a string of past failures in diabetes drug development.
Shares shorted by the overall market
vTv Therapeutics is developing drugs for metabolic diseases such as diabetes. This requires extensive R&D. This chart measures overall "risk appetite." When it falls (i.e., fear increases), investors are unwilling to fund multi-year clinical trials, and biotech stocks without revenue come under severe pressure.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator vTv Therapeutics Inc. (VTVT)
This chart for vTv Therapeutics is a binary betting indicator. The company is targeting giant markets like diabetes and Alzheimer's disease. The potential rewards are enormous, but the risks are also high. Any encouraging trial data triggers euphoria and "overheating" (above 70). The slightest hint of insufficient efficacy or side effects leads to panic selling and "oversold" (below 30).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-vTv-Therapeutics-Inc.-VTVT&v=1772650124399 "RSI 14 indicator chart for the company's stock vTv Therapeutics Inc. (VTVT)")
RSI 14 Market Segment - Pharma metabolism
vTv Therapeutics (VTVT) is a biotech company focused on *diabetes* and *Alzheimer's*. The "Pharma Metabolism" (biotech) sector thrives on news. RSI_14_Seg shows the "temperature" of this entire segment. It's vital to understand: is VTVT's growth due to its R&D or is the *entire* biotech sector simply overheated by expectations?
RSI 14 for the overall market
vTv Therapeutics (VTVT) is a biotech R&D company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic poses the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast VTVT (vTv Therapeutics Inc.)
vTv Therapeutics is a clinical-stage biotech focused on treating type 1 diabetes and Alzheimer's disease. This chart shows the speculative average price target from analysts, which is almost entirely dependent on their belief in the success of clinical trials for these risky but important drugs.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-VTVT-vTv-Therapeutics-Inc.&v=1772650124428 "A chart showing analyst consensus forecasts for the expected stock price. VTVT (vTv Therapeutics Inc.)")
The difference between the consensus estimate and the actual stock price VTVT (vTv Therapeutics Inc.)
vTv Therapeutics (VTVT) is a biotech company developing small molecules to treat diabetes and Alzheimer's. This chart is a barometer of their R&D. It measures the vast gap between the speculative price and the consensus target, reflecting the enormous (but risky) potential analysts see in their pipeline.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-VTVT-vTv-Therapeutics-Inc.&v=1772650124447 "A chart showing the difference between the consensus forecast and the actual stock price. VTVT (vTv Therapeutics Inc.)")
Analyst consensus forecast for stock prices by market segment - Pharma metabolism
vTv Therapeutics (VTVT) is a clinical-stage biotech developing small molecules for the treatment of type 1 diabetes and other metabolic disorders. This chart shows general expectations for the metabolism sector, reflecting experts' confidence in the company's R&D pipeline in this complex field.
Analysts' consensus forecast for the overall market share price
vTv Therapeutics is a biotech company specializing in developing tablet-based treatments for type 1 diabetes and other metabolic diseases. This chart shows the overall risk appetite. For vTv, a high-risk clinical-stage company, overall market optimism is critical to raising the capital needed to fund long-term clinical trials.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index vTv Therapeutics Inc.
vTv Therapeutics is a clinical-stage biotech focused on metabolic diseases. Their key bet is a type 1 diabetes drug (TTP399), which is designed to work in conjunction with insulin. This chart is a pure indicator of their R&D confidence. It doesn't reflect revenue, but rather a speculative assessment of their scientific approach and clinical trial data.
AKIMA Market Segment Index - Pharma metabolism
vTv Therapeutics (VTVT) is a clinical-stage biopharmaceutical company specializing in the treatment of metabolic diseases such as type 1 diabetes and Alzheimer's disease. The chart shows the segment average, allowing investors to assess how vTvT's risks and research compare to the average in the metabolic and neuroscience research sector.
The AKIM Index for the overall market
vTv Therapeutics is a biotech company developing oral medications for the treatment of type 1 diabetes (in partnership) and other diseases. This chart, which reflects the market average, provides a macro backdrop. It helps assess how this company, which is optimizing its asset portfolio, compares to overall economic trends.
